title: [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
authors.affiliation: Centrum för utvärdering av medicinsk teknologi (CMT), Linköpings universitet, och kvinnokliniken, Nyköpings. peterbistoletti@yahoo.com
authors.forename: Peter
authors.initials: P
authors.lastname: Bistoletti
authors.forename: Agneta
authors.initials: A
authors.lastname: Ellström
authors.forename: Joakim
authors.initials: J
authors.lastname: Dillner
authors.forename: Karin
authors.initials: K
authors.lastname: Sennfält
authors.forename: Pär
authors.initials: P
authors.lastname: Sparén
authors.forename: Björn
authors.initials: B
authors.lastname: Strander
mesh_terms: D000328:Adult; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D018803:Models, Economic; D027383:Papillomaviridae / Q000302:isolation & purification*; D011237:Predictive Value of Tests; D012307:Risk Factors; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000821:virology; D014626:Vaginal Smears / Q000191:economics*